STIPE Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 39691175
Axeltorv 2, 1609 København V
prj@gorrissenfederspiel.com
Income statement (kEUR)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -1 330.86 | -2 948.72 | -4 086.58 | -6 617.05 | -3 456.56 |
| Employee benefit expenses | - 739.85 | -1 608.16 | -1 990.63 | -2 191.79 | -1 501.01 |
| EBIT | -2 070.71 | -4 556.88 | -6 077.21 | -8 808.83 | -4 957.57 |
| Other financial income | 0.81 | 9.59 | 3.50 | 35.30 | 42.14 |
| Other financial expenses | -82.99 | -56.65 | - 147.97 | - 235.53 | - 267.61 |
| Net income from associates (fin.) | -9.37 | ||||
| Pre-tax profit | -2 152.89 | -4 603.94 | -6 221.68 | -9 009.07 | -5 192.41 |
| Income taxes | 369.22 | 736.28 | 736.28 | 736.28 | 736.28 |
| Net earnings | -1 783.67 | -3 867.65 | -5 485.39 | -8 272.78 | -4 456.13 |
Assets (kEUR)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Prepayments and accrued income | 25.35 | ||||
| Current other receivables | 77.10 | 140.50 | 8 157.75 | 146.45 | 146.80 |
| Current deferred tax assets | 369.22 | 938.49 | 736.28 | 736.28 | 736.28 |
| Short term receivables total | 446.32 | 1 078.99 | 8 894.04 | 882.74 | 908.43 |
| Cash and bank deposits | 7 601.90 | 3 545.95 | 5 617.44 | 5 319.09 | 2 309.18 |
| Cash and cash equivalents | 7 601.90 | 3 545.95 | 5 617.44 | 5 319.09 | 2 309.18 |
| Balance sheet total (assets) | 8 048.22 | 4 624.93 | 14 511.48 | 6 201.83 | 3 217.61 |
Equity and liabilities (kEUR)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 17.19 | 17.19 | 32.06 | 32.06 | 32.06 |
| Other reserves | 7 971.18 | ||||
| Retained earnings | 8 455.86 | 7 614.88 | 7 714.03 | 10 199.83 | 1 927.04 |
| Profit of the financial year | -1 783.67 | -3 867.65 | -5 485.39 | -8 272.78 | -4 456.13 |
| Shareholders equity total | 6 689.38 | 3 764.41 | 10 231.89 | 1 959.11 | -2 497.02 |
| Non-current loans from credit institutions | 942.68 | 2 758.64 | 2 906.17 | 5 150.03 | |
| Non-current other liabilities | 22.25 | 110.37 | |||
| Non-current liabilities total | 964.94 | 110.37 | 2 758.64 | 2 906.17 | 5 150.03 |
| Current trade creditors | 323.03 | 513.40 | 1 430.78 | 1 041.30 | 490.73 |
| Other non-interest bearing current liabilities | 70.87 | 236.75 | 90.17 | 295.25 | 73.88 |
| Current liabilities total | 393.90 | 750.16 | 1 520.96 | 1 336.55 | 564.61 |
| Balance sheet total (liabilities) | 8 048.22 | 4 624.93 | 14 511.48 | 6 201.83 | 3 217.61 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.